For research use only. Not for therapeutic Use.
Zandatrigine (NBI-921352) is a sodium channel protein type 8 subunit alpha (Scn8α) blocker[1].
| Catalog Number | I033077 |
| CAS Number | 2154406-04-7 |
| Synonyms | 4-[[(3S)-1-benzylpyrrolidin-3-yl]-methylamino]-2-fluoro-5-methyl-N-(1,3-thiazol-4-yl)benzenesulfonamide |
| Molecular Formula | C22H25FN4O2S2 |
| Purity | ≥95% |
| InChI | InChI=1S/C22H25FN4O2S2/c1-16-10-21(31(28,29)25-22-14-30-15-24-22)19(23)11-20(16)26(2)18-8-9-27(13-18)12-17-6-4-3-5-7-17/h3-7,10-11,14-15,18,25H,8-9,12-13H2,1-2H3/t18-/m0/s1 |
| InChIKey | UCSHINHOAVARGQ-SFHVURJKSA-N |
| SMILES | CC1=CC(=C(C=C1N(C)C2CCN(C2)CC3=CC=CC=C3)F)S(=O)(=O)NC4=CSC=N4 |
| Reference | [1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022. |
